ArticlePreventive medicine2018
A comprehensive examination of own- and cross-price elasticities of tobacco and nicotine replacement products in the U.S.
Article in Preventive medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review for the impacts of global approaches to regulating electronic nicotine products.Journal of global health · 2023Pooled it
- Reasons for not using e-cigarettes among adults who smoke: findings from the 2019-2021 Euromonitor International's Voice of the Consumer: Nicotine Survey in 20 countries.BMC public health · 2025Article
- How the sales of oral nicotine pouches correlate with prices and respond to taxes on cigarettes and e-cigarettes.Addiction (Abingdon, England) · 2025Article
- Evaluating trends in cigarette and HTP use in Japan and measurement issues in the National Health and Nutrition Survey.Tobacco control · 2025Observational
- Article
- Effect of e-cigarette taxes on e-cigarette and cigarette retail prices and sales, USA, 2014-2019.Tobacco control · 2025Article
- Article
- How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016-2020 International Tobacco Control United States surveys.Addiction (Abingdon, England) · 2024Article
- Excise taxes and pricing activities of e-liquid products sold in online vape shops.Tobacco control · 2023Article
- The effect of cigarette and e-cigarette taxes on prescriptions for smoking cessation medications.Health services research · 2023Article
- Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Impacts of Tax and Flavor Tobacco Policies on San Francisco Bay Area Tobacco Prices.Evaluation review · 2023Article
- Tax incidence of electronic nicotine delivery systems (ENDS) in the USA.Tobacco control · 2023Article
- Trends in Over-the-Counter Nicotine Replacement Therapy Sales, U.S., 2017‒2020.American journal of preventive medicine · 2023Article
- Monitoring and Combating Waterpipe Tobacco Smoking Through Surveillance and Taxation.JMIR public health and surveillance · 2023Article
- The Short-Term and Long-Term Associations Between Receiving Tobacco Discounts or Coupons and Smoking Cessation Among U.S. Adult Cigarette Smokers With Intention to Quit.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- The effect of e-cigarette taxes on prepregnancy and prenatal smoking.Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management] · 2023Article
- The effects of e-cigarette taxes on e-cigarette prices and tobacco product sales: Evidence from retail panel data.Journal of health economics · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
While much is known about the demand for cigarettes, research on the demand for non-cigarette tobacco products and the cross-price impacts among those products is limited. This study aims to comprehensively examine the own- and cross-price elasticities of demand for tobacco and nicotine replacement products (NRPs) in the U.S. We analyzed market-level quarterly data on sales and prices of 15 different types of tobacco products and NRPs from 2007 to 2014, compiled from retail store scanner data. Fixed effects models with controls were used to estimate their own-price elasticities and cross-price elasticities between cigarettes and the other 14 products. Our results show that, except for cigars, the demand for combustible tobacco products was generally elastic, with the estimated own-price elasticity >1 (10% increase in prices reduces sales by >10%). The own-price elasticities for smokeless tobacco products were smaller than those for combustible tobacco, although not always significant. The demand for electronic cigarettes and NRPs was found to be elastic. The cross-price elasticities with respect to cigarettes were positive for cigarillos, little cigars, loose tobacco, pipe tobacco, electronic cigarettes and NRPs, but only results for little cigars, loose tobacco, pipe tobacco, and dissolvable lozenges were consistently significant. Our findings suggest demand for tobacco products and NRPs was responsive to changes in their own prices. Substitutions or positive cross-price impacts between cigarettes and certain other products exist. It is important that tobacco control policies take into account both own- and cross-price impacts among tobacco products and NRTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.